Genovate Biotechnology Co., Ltd. (4130.TWO)

24.40 +0.05 (+0.21%) At close: 01:30PM CST

Genovate Biotechnology Co., Ltd.

No. 1, Gongye 1st Road
Hsinchu Industrial Zone Hukou Township
Hsinchu City 30351
Taiwan
886 3 598 2221
https://www.genovate-bio.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 194

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Zheng Chen	Chairman & CSO	N/A	N/A	1952
Chia-Chen Chu	General Manager & Director	N/A	N/A	N/A
Ming Gui Peng	Deputy General Manager of Operations	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.

Description

Genovate Biotechnology Co., Ltd. operates as a specialty pharmaceutical company in Taiwan. It offers central nervous system drugs, cardiovascular drugs, musculoskeletal drugs, immune preparation drugs, anti-infective agents, anticancer drugs, anti-viral drugs, respiratory drugs, genitourinary drugs, and gastrointestinal drugs. The company manufactures active pharmaceutical ingredients, intermediates, controlled release medicine, and cosmetic products. Genovate Biotechnology Co., Ltd. was founded in 1982 and is based in Hsinchu City, Taiwan.

Corporate governance

Genovate Biotechnology Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.